This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
3132 Use of circulating tumor cells as response evaluation criteria to erlotinib treatment in EGFR wild-type metastatic lung cancer patients. (September 2015)
Record Type:
Journal Article
Title:
3132 Use of circulating tumor cells as response evaluation criteria to erlotinib treatment in EGFR wild-type metastatic lung cancer patients. (September 2015)
Main Title:
3132 Use of circulating tumor cells as response evaluation criteria to erlotinib treatment in EGFR wild-type metastatic lung cancer patients